News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Capital Increase in Genmab A/S (GEN.CO) as a Result of Execution of a Private Placement to Johnson & Johnson (JNJ) Development Corporation


10/16/2012 9:44:33 AM

Copenhagen, Denmark; October 16, 2012 – Genmab A/S (OMX: GEN) announces completion of the private placement of 5,400,000 new shares of DKK 1 nominal value each in Genmab A/S at a subscription price of DKK 88 per new share to Johnson & Johnson Development Corporation, raising gross proceeds to Genmab of DKK 475,200,000.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES